Over a hundred heart patients in the US will undergo trial for an innovative, computer-assisted surgery this fall.
The FDA plans to try the new computational medicine approach, called Optimal Target Identification via Modelling of Arrhythmogenesis (OPTIMA), with 160 heart patients, Engadget reports.
By using an MRI scan, the team creates a model of the heart's atria chambers, complete with simulated virtual cells with an electrical pulse to see where an irregular heartbeat develops.
After operating on the virtual model multiple times for current or future complications, the team designs a single treatment plan which the surgeon simply follows when operating in real-time. If FDA-approved, OPTIMA may soon make its way to hospitals for cost-efficient treatments.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app